Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole for Dry Eye in Pterygium
NCT02782260Phase 2Unknown
- Sponsor
- Ariel University
- Start
- Jul 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of dipyridamole in dry eye syndrome (DED) and pterygium, sponsored by Ariel University. Primary endpoints: Change in tear secretion rate at 6 months and Reduction in dry eye symptomology at 6 months. Status: unknown.
02
Drugs
dipyridamole
03
Conditions
dry eye syndrome (DED)pterygium
Beyond the preview
Go deeper on NCT02782260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782260.